15-20534522-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001145004.2(GOLGA6L6):c.1912C>A(p.Gln638Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000551 in 1,522,104 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145004.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GOLGA6L6 | NM_001145004.2 | c.1912C>A | p.Gln638Lys | missense_variant | 8/9 | ENST00000619213.1 | NP_001138476.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GOLGA6L6 | ENST00000619213.1 | c.1912C>A | p.Gln638Lys | missense_variant | 8/9 | 5 | NM_001145004.2 | ENSP00000480376 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000548 AC: 80AN: 145860Hom.: 0 Cov.: 40
GnomAD3 exomes AF: 0.000590 AC: 87AN: 147418Hom.: 4 AF XY: 0.000484 AC XY: 38AN XY: 78486
GnomAD4 exome AF: 0.000551 AC: 758AN: 1376144Hom.: 7 Cov.: 53 AF XY: 0.000514 AC XY: 349AN XY: 679224
GnomAD4 genome AF: 0.000548 AC: 80AN: 145960Hom.: 0 Cov.: 40 AF XY: 0.000632 AC XY: 45AN XY: 71240
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.1990C>A (p.Q664K) alteration is located in exon 8 (coding exon 8) of the GOLGA6L6 gene. This alteration results from a C to A substitution at nucleotide position 1990, causing the glutamine (Q) at amino acid position 664 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at